Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Oncotarget|October 10, 2015
The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytesShu-Ting Liu, Shih-Ming Huang, Ching-Liang Ho, et al.
Plos One|March 19, 2019
The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillationYi-Hsin Chan, Kuang-Tso Lee, Yi-Wei Kao, et al.
Journal of Biomedical Science|July 24, 2013
Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat modelSheng-Ping Huang, Chun-Hsiang Huang, Jia-Fwu Shyu, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 24, 2021
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort studyTze-Fan Chao, Yi-Hsin Chan, Ta-Chuan Tuan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2023
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitorsHsin-Fu Lee, Yi-Hsin Chan, Chi Chuang, et al.
Diabetes, Obesity & Metabolism|August 12, 2024
Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium-glucose cotransporter 2 inhibitors users versus non-users. A propensity score matching National Cohort StudyTzu-Yang Chen, Hsin-Fu Lee, Yi-Hsin Chan, et al.
International Journal of Cardiology|March 22, 2018
The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillationHsin-Fu Lee, Yi-Hsin Chan, Hui-Tzu Tu, et al.
JACC. Asia|December 14, 2023
Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: An Asian PerspectiveTze-Fan Chao, Ngai-Yin Chan, Yi-Hsin Chan, et al.
Plos One|March 18, 2016
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based StudyYi-Hsin Chan, Lung-Sheng Wu, Shang-Hung Chang, et al.
Journal of the American College of Cardiology|September 24, 2016
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial FibrillationYi-Hsin Chan, Chi-Tai Kuo, Yung-Hsin Yeh, et al.
Pageof 19